share

(6R,7R,8R,13As)-5,6,7,8-Tetrahydro-1,2,3,13-Tetramethoxy-6,7-Dimethylbenzo[3,4]Cycloocta[1,2-F][1,3]Benzodioxol-8-Ol CAS NO 51670-42-9


Unit Price:

CAS No.:51670-42-9

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

(6R,7R,8R,13As)-5,6,7,8-Tetrahydro-1,2,3,13-Tetramethoxy-6,7-Dimethylbenzo[3,4]Cycloocta[1,2-F][1,3]Benzodioxol-8-Ol CAS NO 51670-42-9 is a complex, high-purity lignan derivative with a defined stereochemistry. This compound serves as a critical intermediate and reference standard in advanced pharmaceutical research and development. It is primarily required by pharmaceutical R&D laboratories, academic research institutions, and fine chemical manufacturers engaged in the synthesis of novel bioactive molecules.

Application

  • Pharmaceutical Intermediate: A key chiral building block for the synthesis of novel drug candidates, particularly in oncology and neurology research.
  • Reference Standard: Used for analytical method development, validation, and quality control (QC/QA) in pharmaceutical manufacturing.
  • Biochemical Research: Investigation of biological pathways and enzyme interactions due to its specific stereochemical configuration.
  • Natural Product Synthesis: Serves as a synthetic target or intermediate in the total synthesis of complex natural products with lignan backbones.
  • Process Chemistry Development: Utilized in scaling up synthetic routes and optimizing catalytic processes for stereoselective synthesis.

Basic Information

Item Details
Product Name (6R,7R,8R,13As)-5,6,7,8-Tetrahydro-1,2,3,13-Tetramethoxy-6,7-Dimethylbenzo[3,4]Cycloocta[1,2-F][1,3]Benzodioxol-8-Ol
CAS No. 51670-42-9
Molecular Formula C23H28O7
Molecular Weight 416.47 g/mol
Synonyms (-)-Galbelgin; Galbelgin; (6R,7R,8R,13aR)-5,6,7,8-Tetrahydro-1,2,3,13-tetramethoxy-6,7-dimethylbenzo[3,4]cycloocta[1,2-f][1,3]benzodioxol-8-ol; Benzo[3,4]cycloocta[1,2-f][1,3]benzodioxol-8-ol, 5,6,7,8-tetrahydro-1,2,3,13-tetramethoxy-6,7-dimethyl-, (6R,7R,8R,13aR)-; Lignan derivative Galbelgin
EINECS Contact for details

Quality Control

Our (6R,7R,8R,13As)-5,6,7,8-Tetrahydro-1,2,3,13-Tetramethoxy-6,7-Dimethylbenzo[3,4]Cycloocta[1,2-F][1,3]Benzodioxol-8-Ol is produced under strict quality management systems. Each batch undergoes comprehensive analytical testing, including chiral purity verification, to ensure it meets the stringent requirements for research and development. Certificates of Analysis (COA) with detailed chromatographic data (HPLC, Chiral HPLC) are provided and available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). The container should be kept in a desiccator or under an inert atmosphere for long-term storage to maintain stability.

Specification

Item Specification
Appearance White to off-white crystalline powder
Identification (IR) Conforms to structure
Identification (HPLC) Retention time matches reference standard
Purity (HPLC) ≥ 98.0%
Chiral Purity (Chiral HPLC) ≥ 99.0% ee
Loss on Drying ≤ 0.5%
Residue on Ignition ≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.